Ms. Hao Li – Tumor Immunology – Young Scientist Award

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.Ā  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)

 

Mrs. Feryal Dabbagh-Gorjani – Tumor Immunology – Best Researcher Award

Mrs. Feryal Dabbagh-Gorjani - Tumor Immunology - Best Researcher Award

Foroogh Salamat - Iran

Author Profile

Orcid

EARLY ACADEMIC PURSUITS

Feryal Dabbagh Gorjani embarked on her academic journey with a strong foundation in the medical sciences. She pursued a B.Sc in Clinical Laboratory from 2008 to 2010 at the Preclinical School of Iran University of Medical Science, Tehran, Iran. Prior to that, she obtained an associated degree in Clinical Laboratory from the Preclinical School of Islamic Azad University, Tehran Medical Sciences Branch, from 2005 to 2007. Her educational journey culminated in an M.Sc in Medical Immunology from 2011 to 2014 at the Medical School of Shiraz University of Medical Science, Shiraz, Iran.

PROFESSIONAL ENDEAVORS

From December 2023 onwards, Feryal Dabbagh Gorjani has been engaged as a medical advisor at Forough Salamat Mehregan, the official representative of the American company Fairhaven Health. Her role in this capacity involves providing expertise and guidance in medical matters, presumably within the realm of immunology and clinical laboratory science.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Throughout her academic and professional journey, Feryal Dabbagh Gorjani has likely contributed to the field of medical immunology and clinical laboratory science. And her Specific research focuses on immunological diagnostics, disease pathogenesis, and therapeutic interventions.

IMPACT AND INFLUENCE

Her work as a medical advisor suggests that she plays a crucial role in shaping decisions related to health and wellness. Her expertise in medical immunology and clinical laboratory science likely contributes to advancements in diagnostic accuracy, treatment efficacy, and patient care.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT

Feryal Dabbagh Gorjani's legacy and future contributions lie in her ongoing work as a medical advisor and her potential for further advancements in the fields of medical immunology and clinical laboratory science. As she continues to apply her expertise and knowledge in healthcare settings, her contributions are likely to impact patient outcomes, research advancements, and the broader medical community. Future endeavors may include continued research, publications, and collaborative efforts to address emerging challenges in immunological diagnostics and therapeutics.

Notable Publications

A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases. 2024

COVID-19 and neurological complications. 2022

EcoImmunology: Evaluative Aspects and Future Perspectives. 2018

Investigating the Association of IL-17A and IL-17F with Susceptibility to Preeclampsia in Iranian Women. 2015

Differences in the expression of TLRs and inflammatory cytokines in preeclamptic compared with healthy pregnant women. 2014